BRO melanoma cells, where G0‐positive cells increased following dacarbazine treatment, were characterized by a similar signaling pathways pattern dysregulation, where the ‘VEGFA‐VEGFR2’ signaling pathway was the most altered, with 118 genes downregulated upon dacarbazine treatment and 6 upregulated. The gene discussed is KDR; the disease is melanoma.